Stockscreener 앱 받기
10.10
3.57%
-0.395
전일 마감가:
$10.49
열려 있는:
$10.21
하루 거래량:
1.02M
Relative Volume:
0.83
시가총액:
$538.58M
수익:
$1.02B
순이익/손실:
$-757.20M
주가수익비율:
-0.6839
EPS:
-14.76
순현금흐름:
$-257.90M
1주 성능:
+6.81%
1개월 성능:
+10.55%
6개월 성능:
+96.79%
1년 성능:
+15.34%
1일 변동 폭
$10.04
$10.54
1주일 범위
$9.21
$13.41
52주 변동 폭
$4.02
$13.41
Emergent Biosolutions Inc Stock (EBS) Company Profile
명칭
Emergent Biosolutions Inc
전화
240-631-3200
주소
300 PROFESSIONAL DR, GAITHERSBURG, MD
EBS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EBS
Emergent Biosolutions Inc
|
10.10 | 550.93M | 1.02B | -757.20M | -257.90M | -14.76 |
|
ZTS
Zoetis Inc
|
124.80 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.58 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.339 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.39 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.66 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-22 | 개시 | Rodman & Renshaw | Buy |
| 2024-03-07 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-11-20 | 재개 | JP Morgan | Underweight |
| 2023-08-29 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-04-10 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-03-17 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-11-10 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-04-29 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-01-20 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2021-11-08 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2021-05-05 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 개시 | The Benchmark Company | Buy |
| 2021-02-24 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2021-02-19 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-01-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-09-14 | 재개 | JP Morgan | Neutral |
| 2020-07-31 | 재확인 | Chardan Capital Markets | Buy |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-09-04 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2018-11-02 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-08-03 | 재확인 | Chardan Capital Markets | Buy |
| 2018-06-13 | 개시 | Argus | Buy |
| 2018-04-25 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2018-01-16 | 재확인 | Chardan Capital Markets | Buy |
| 2016-06-28 | 재확인 | Singular Research | Buy |
| 2016-04-15 | 개시 | Chardan Capital Markets | Buy |
| 2016-03-28 | 개시 | Singular Research | Buy |
| 2016-02-19 | 개시 | Wells Fargo | Outperform |
| 2014-05-15 | 개시 | Summer Street Research | Buy |
| 2011-05-31 | 재확인 | WBB Securities | Strong Buy |
| 2011-01-10 | 재확인 | Wedbush | Outperform |
| 2010-11-05 | 재확인 | Wedbush | Outperform |
| 2010-08-18 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2010-08-06 | 재확인 | Caris & Company | Buy |
모두보기
Emergent Biosolutions Inc 주식(EBS)의 최신 뉴스
Emergent Biosolutions (NYSE:EBS) Shares Down 15.6%Should You Sell? - MarketBeat
Will Emergent BioSolutions Inc. stock deliver consistent dividendsFed Meeting & Safe Capital Growth Stock Tips - newser.com
Visual analytics tools that track Emergent BioSolutions Inc. performancePortfolio Growth Summary & Daily Growth Stock Tips - newser.com
What makes Emergent BioSolutions Inc. stock appealing to growth investorsProfit Target & Low Risk High Win Rate Stock Picks - newser.com
Analyzing Emergent BioSolutions Inc. with multi timeframe chartsQuarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Emergent BioSolutions Inc.'s (NYSE:EBS) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 29% Over Last Week - 富途牛牛
Will Emergent BioSolutions Inc. stock sustain high P E ratiosGap Down & Long-Term Investment Growth Plans - newser.com
How Emergent BioSolutions Inc. (ER4) stock behaves in tightening cyclesWeekly Stock Report & High Return Trade Guides - newser.com
Why Emergent BioSolutions Inc. (ER4) stock is listed among top recommendations2025 Short Interest & Long-Term Safe Investment Plans - newser.com
Why Emergent BioSolutions Inc. (ER4) stock remains top ratedQuarterly Profit Report & Reliable Intraday Trade Alerts - newser.com
Will Emergent BioSolutions Inc. stock justify high valuation2025 Major Catalysts & Real-Time Volume Spike Alerts - newser.com
Wolverine Asset Management LLC Raises Stock Position in Emergent Biosolutions Inc. $EBS - MarketBeat
Is Emergent BioSolutions Inc. stock dividend yield sustainableJuly 2025 Highlights & Consistent Growth Stock Picks - newser.com
Published on: 2025-11-03 02:38:18 - newser.com
How Emergent BioSolutions Inc. stock benefits from tech adoptionWeekly Volume Report & Weekly High Conviction Ideas - newser.com
Published on: 2025-11-02 23:34:34 - newser.com
Combining price and volume data for Emergent BioSolutions Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
Chart based exit strategy for Emergent BioSolutions Inc.2025 Buyback Activity & Weekly Return Optimization Alerts - newser.com
Reversal indicators forming on Emergent BioSolutions Inc. stockQuarterly Profit Report & Reliable Trade Execution Plans - newser.com
Published on: 2025-11-02 23:01:50 - newser.com
Will Emergent BioSolutions Inc. stock return to pre crisis levelsMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Emergent BioSolutions (EBS) Is Up 28.1% After Strong Q3 Results and Raised 2025 Guidance Has the Bull Case Changed? - Yahoo Finance
Applying Wyckoff theory to Emergent BioSolutions Inc. stock2025 Top Gainers & Verified Entry Point Signals - newser.com
Published on: 2025-11-02 12:46:41 - newser.com
Published on: 2025-11-02 12:32:07 - newser.com
Will Emergent BioSolutions Inc. benefit from macro trendsJuly 2025 Institutional & High Conviction Buy Zone Picks - newser.com
Emergent BioSolutions Hits New 52-Week High of $13.41, Up 100.94% - Markets Mojo
Why Emergent BioSolutions Inc. stock remains resilient2025 Top Gainers & Daily Price Action Insights - newser.com
Why Emergent BioSolutions Inc. stock could rally in 2025July 2025 Fed Impact & Safe Investment Capital Preservation Plans - newser.com
Emergent Biosolutions (NYSE:EBS) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Is Emergent BioSolutions Inc. a candidate for recovery playVolume Spike & Reliable Price Action Trade Plans - newser.com
Emergent Biosolutions (NYSE:EBS) Hits New 52-Week HighHere's Why - MarketBeat
Published on: 2025-11-01 03:39:59 - newser.com
Published on: 2025-11-01 02:24:00 - newser.com
Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out? - sharewise.com
Will breakout in Emergent BioSolutions Inc. lead to full recoveryTreasury Yields & Advanced Swing Trade Entry Alerts - newser.com
Understanding Emergent BioSolutions Inc.’s price movementWeekly Market Report & Fast Moving Stock Watchlists - newser.com
Emergent BioSolutions’ Earnings Call Highlights Strong Growth - The Globe and Mail
Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding - GlobeNewswire Inc.
Emergent Biosolutions (NYSE:EBS) Shares Gap Up After Strong Earnings - MarketBeat
Emergent BioSolutions Raises Full-Year Revenue Guidance - MSN
Emergent Biosolutions Inc (EBS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.19%
0.45%
자본화:
|
볼륨(24시간):